journal article·2018-10

A novel bi-phase Sr-doped magnesium phosphate/calcium silicate composite scaffold and its osteogenesis promoting effect

Shengyi Li, Ximing Pu, Xianchun Chen, Xiaoming Liao, Zhongbing Huang, Guangfu Yin

Ceramics International· Volume 44· Issue 14
Publisher page

Abstract

Abstract In order to improve the osteoconductivity and the osteoinductivity of bone tissue engineering scaffold, a novel bi-phase strontium-doped magnesium phosphate/calcium silicate (Sr-MP/CSC) composite scaffold was fabricated by the self-solidifying/particulate leaching method. The bi-phase composition of the well-crystallized struvite grains wrapped by the calcium silicate floccules was propitious to the deformability and toughness of composite scaffold, and the porous structure with interconnected macropores of 100–400 µm was beneficial to supporting the tissue growth and transporting nutrients and metabolites. When the Sr-MP/CSC composite scaffolds were degraded in the simulated physiological environment, the doped strontium could be sustainably released together with Ca2+, Mg2+, PO43- and silidous ions. The proliferation and osteogenic differentiation of rat bone marrow stromal cells (BMSCs) on these composite scaffolds were obviously promoted. More valuably, the Sr-doped MP/CSC scaffolds exhibited the more obvious promotion to ALP activity, Col I and OCN expression than the un-doped MP/CSC scaffold, especially in the later stage. The results suggested that the strontium combined with calcium, magnesium and silicon could synergically promote osteogenesis, and the Sr-MP/CSC composite might be one of the promising bone tissue engineering scaffold materials.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Magnesium Oxide Properties and Applications · Phosphorus and nutrient management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. Osteoinductive biomaterials-properties and relevance in bone repair10.1002/term.5 ↗
2. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(dl-lactide-co-glycolide) films10.1016/j.biomaterials.2009.01.029 ↗
3. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic10.1016/j.biomaterials.2004.09.019 ↗
4. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics10.1016/j.biomaterials.2008.03.013 ↗
5. The responses of osteoblasts, osteoclasts and endothelial cells to zirconium modified calcium-silicate-based ceramic10.1016/j.biomaterials.2008.08.006 ↗
6. Calcium silicate/calcium phosphate biphasic cements for vital pulp therapy: chemical-physical properties and human pulp cells response10.1007/s00784-015-1443-2 ↗
7. Porous scaffold prepared from α′L-Dicalcium silicate doped with phosphorus for bone grafts10.1016/j.ceramint.2017.09.208 ↗
8. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics10.1002/jbm.b.30779 ↗
9. Development of self-setting calcium-phosphate cement10.2109/jcersj.99.954 ↗
10. Evaluation of inherent toxicology and biocompatibility of magnesium phosphate bone cement10.1016/j.colsurfb.2009.12.010 ↗
11. Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor10.1152/ajpcell.00614.2008 ↗
12. Self-setting bioactive calcium-magnesium phosphate cement with high strength and degradability for bone regeneration10.1016/j.actbio.2008.06.020 ↗
13. Evaluation of inherent toxicology and biocompatibility of magnesium phosphate bone cement10.1016/j.colsurfb.2009.12.010 ↗
14. Hierarchically microporous/macroporous scaffold of magnesium-calcium phosphate for bone tissue regeneration10.1016/j.biomaterials.2009.11.005 ↗
15. Low temperature fabrication of magnesium phosphate cement scaffolds by 3D powder printing
16. Novel tricalcium silicate/magnesium phosphate composite bone cement having high compressive strength, in vitro bioactivity and cytocompatibility10.1016/j.actbio.2015.04.012 ↗
17. In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model10.1016/j.actbio.2011.05.022 ↗
18. Cementing mechanism of potassium phosphate based magnesium phosphate cement10.1016/j.ceramint.2012.04.083 ↗
19. The chemistry of dicalcium silicate mineral10.1007/BF00569274 ↗
20. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro10.1016/S8756-3282(02)00950-X ↗
21. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics10.1016/j.biomaterials.2011.01.004 ↗
22. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis10.1016/j.bone.2009.07.082 ↗
23. Three-dimensional ingrowth of bone cells within biodegradable cryogel scaffolds in bioreactors at different regimes10.1089/ten.tea.2007.0277 ↗
24. Localized delivery of growth factors for angiogenesis and bone formation in tissue engineering10.1016/j.intimp.2013.04.001 ↗
25. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo10.1089/ten.tea.2010.0555 ↗
26. Strength reliability and in vitro degradation of three-dimensional powder printed strontium-substituted magnesium phosphate scaffolds10.1016/j.actbio.2015.11.050 ↗
27. Strontium ranelate: a novel mode of action leading to renewed bone quality10.1007/s00198-004-1809-9 ↗
28. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments10.1097/01.blo.0000200236.84189.87 ↗
29. Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells10.1002/jbm.a.31975 ↗
30. Ionic substitutions in calcium phosphates synthesized at low temperature10.1016/j.actbio.2009.12.041 ↗
31. In vitro and animal study of novel nano-hydroxyapatite/poly(epsilon-caprolactone) composite scaffolds fabricated by layer manufacturing process10.1089/ten.tea.2008.0190 ↗
32. Preparation and characterization of bioactive mesoporous wollastonite-polycaprolactone composite scaffold10.1016/j.biomaterials.2008.10.046 ↗
33. Porous diopside (CaMgSi2O6) scaffold: a promising bioactive material for bone tissue engineering10.1016/j.actbio.2009.12.022 ↗
34. Novel magnesium phosphate cements with high early strength and antibacterial properties10.1016/j.actbio.2010.12.008 ↗
35. The effect of carboxyl-terminal propeptide of type I collagen (c-Propeptide) on collagen synthesis of preosteoblasts and osteoblasts10.1007/s002230001150 ↗
36. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment10.1177/10454411990100010201 ↗
37. Dissolution behavior of CaO-MgO-SiO2-based multiphase bioceramic powders and effects of the released ions on osteogenesis10.1002/jbm.a.36154 ↗